Ing Groep Nv Astrazeneca PLC Transaction History

Ing Groep Nv

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 27, 2023	BUY	$64.85 - $71.7 $4.36 Million - $4.82 Million	67,231 Added 1897.57%	70,774 $4.79 Million
Q2 2023 Aug 07, 2023	SELL	$69.91 - $75.81 $59,912 - $64,969	-857 Reduced 19.48%	3,543 $253,000
Q1 2023 May 09, 2023	SELL	$63.15 - $71.6 $3.21 Million - $3.64 Million	-50,801 Reduced 92.03%	4,400 $305,000
Q4 2022 Feb 10, 2023	BUY	$54.21 - $70.44 $511,633 - $664,812	9,438 Added 20.62%	55,201 $3.74 Million
Q3 2022 Nov 14, 2022	BUY	$53.02 - $135.75 $639,050 - $1.64 Million	12,053 Added 35.75%	45,763 $2.51 Million
Q2 2022 Aug 08, 2022	BUY	$59.26 - $71.14 $1.12 Million - $1.34 Million	18,823 Added 126.44%	33,710 $2.23 Million
Q1 2022 May 13, 2022	BUY	$55.72 - $67.12 $829,503 - $999,215	14,887 New	14,887 $988,000

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Ing Groep Nv, based on Form 13F filings with the SEC.

Stay updated on Ing Groep Nv with notifications on news.